Answer Summary

Members offered guidance on affording Xeljanz with Medicare, with the overwhelming consensus being to apply for patient assistance programs... Read more

Members offered guidance on affording Xeljanz with Medicare, with the overwhelming consensus being to apply for patient assistance programs directly through the pharmaceutical company (Xelsource), which can cover the full cost of medication even when Medicare won't allow traditional copay cards. Several members shared their own experiences navigating Medicare coverage, explaining that injectable biologics are often prohibitively expensive under Part D but infusions like Remicade or Orencia may be fully covered under Part B with supplemental insurance, and that Medicare Advantage plans or state Extra Help programs can provide additional financial relief. A recurring theme was the shared frustration of losing employer-based insurance and copay assistance when transitioning to disability, the long wait times and denials many face when applying for SSDI, and the two-year gap before Medicare eligibility begins after approval.